What it sells
The only R&D data cloud for life sciences
Business model breakdown
Buyer: who owns the budget?
Scientific IT, R&D/data leaders and AI leaders at biopharma (pages for AI leader, development, research, scientific IT, quality).
Trigger: what makes them buy now?
UnverifiedFragmented instrument and lab data blocking scientific AI; replatforming legacy SDMS.
Workflow: what inputs become what output?
Integrate instrument/ELN/LIMS data, engineer it into harmonized AI-ready datasets, automate scientific data workflows, run analytics/AI apps (e.g., Chromatography Insights) on Tetra OS with GxP compliance.
Economics: what it saves and how it charges
UnverifiedEnterprise platform subscription plus data-replatforming services; price not published.
Distribution: how it reaches customers
UnverifiedEnterprise demo/contact-led sales into pharma; outcomes pages and CEO content marketing.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2015 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.